Artificial intelligence in glomerular diseases

Autor: Schena, F. P., Magistroni, R., Narducci, F., Abbrescia, D. I., Anelli, V. W., Di Noia, T.

Publikováno v: Pediatric nephrology (Berlin, Germany). 37(11)

In this narrative review, we focus on the application of artificial intelligence in the clinical history of patients with glomerular disease, digital pathology in kidney biopsy, renal ultrasonography imaging, and prediction of chronic kidney disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26fa8c4eec8c5dba30ebf5549d3418f4
https://pubmed.ncbi.nlm.nih.gov/35266037

Site-dependent biological activity of valinomycin analogs bearing derivatizable hydroxyl sites

Autor: Annese, C., Abbrescia, D. I., Catucci, L., D'Accolti, L., Denora, N., Fanizza, I., Fusco, C., La Piana, G.

Publikováno v: Journal of peptide science
19 (2013): 751–757. doi:10.1002/psc.2571
info:cnr-pdr/source/autori:Annese, C.; Abbrescia, D. I.; Catucci, L.; D'Accolti, L.; Denora, N.; Fanizza, I.; Fusco, C.; La Piana, G./titolo:Site-dependent biological activity of valinomycin analogs bearing derivatizable hydroxyl sites/doi:10.1002%2Fpsc.2571/rivista:Journal of peptide science (Print)/anno:2013/pagina_da:751/pagina_a:757/intervallo_pagine:751–757/volume:19

Valinomycin (VLM, 1) is a K+ ionophore cyclodepsipeptide capable of depolarizing mitochondria and inducing apoptosis to several mammalian cell types, including a number of tumor cell lines. With the aim of creating VLM-based ligand-targeted anticance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::14e45a63d98deeff3b08c4b47d650b72
https://publications.cnr.it/doc/274322

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.